Patents by Inventor Charles A. Altar

Charles A. Altar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dual function drugs and uses thereof
    Publication number: 20070142399
    Abstract: Dual action compounds are provided that are inhibitors of catechol-omethyltransferase (COMT) enzyme and are also partial agonists or antagonists of the D2 receptor, or agonists of the D1 receptor, or interact in these ways with both D1 and D2 receptors. Use of the compounds for treating neuropsychiatric disorders, particularly schizophrenia and mild cognitive impairment, is also described.
    Type: Application
    Filed: June 21, 2004
    Publication date: June 21, 2007
    Applicant: Psychiatric Genomics, Inc.
    Inventors: Charles Altar, Malcolm Taylor, Derek Hook, Michael Palfreyman
  • Method of producing analgesia using neurotrophins
    Patent number: 5827823
    Abstract: Infusions of brain-derived neurotrophic factor, neurotrophin-3 or neurotrophin-4 are used to produce analgesia in mammals. In addition, these neurotrophins are used to treat other diseases or disorders mediated by serotonin.
    Type: Grant
    Filed: January 25, 1995
    Date of Patent: October 27, 1998
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Judith Siuciak, Charles A. Altar, Ronald M. Lindsay